Taiwan Research Institute Funds Isis SARS Antisense Research | GenomeWeb

NEW YORK, June 24 - Isis Pharmaceuticals is beginning a search for antisense therapies to the SARS coronavirus, which the Industrial and Technology Research Institute of Taiwan is funding with $2 million, the organizations said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.